Work

Targeting vitamin D receptor (VDR)/immune checkpoint inhibitor receptor ligand PD-L1 axis for immunotherapy of ovarian cancer

Year: 2018

Type: article

Source: Gynecologic Oncology

DOI: 10.1016/j.ygyno.2018.04.103

Authors: R.K. Singh, R. Turner, K. Kim, U. Sivagnanalingam, R.G. Moore

Institutions: University of Rochester Medicine, University of Rochester

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2811410744

FWCI: 0.095

Cites:

Cited by: 3

Related to: 10